Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group
about
Acute lymphoblastic leukaemiaTargeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and FutureNon-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges AheadChildhood acute lymphoblastic leukemia: Integrating genomics into therapyNelarabine in the treatment of pediatric and adult patients with T-cell acute lymphoblastic leukemia and lymphoma.Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia.Increased post-induction intensification improves outcome in children and adolescents with a markedly elevated white blood cell count (≥200 × 10(9) /l) with T cell acute lymphoblastic leukaemia but not B cell disease: a report from the Children's OnImproving outcomes in childhood T-cell acute lymphoblastic leukemia: promising results from the Children's Oncology Group incorporating nelarabine into front-line therapy.A 50-year journey to cure childhood acute lymphoblastic leukemiaImproving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions.Lymphoblastic lymphoma in childhood and adolescence.How to treat relapsed acute lymphoblastic leukemia: transplant vs. conventional chemotherapy.Nelarabine neurotoxicity with concurrent intrathecal chemotherapy: Case report and review of literature.Safety and efficacy of nelarabine in children and young adults with relapsed or refractory T-lineage acute lymphoblastic leukaemia or T-lineage lymphoblastic lymphoma: results of a phase 4 study.Current status and future directions of T-lymphoblastic lymphoma in children and adolescents.Novel therapy for childhood acute lymphoblastic leukemia.Haploidentical hematopoietic stem cell transplantation for paediatric high-risk T-cell acute lymphoblastic leukaemia.Nelarabine associated myotoxicity and rhabdomyolysis.A step forward in acute lymphoblastic leukemia.Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma.Treatment of Older Patients with Acute Lymphoblastic Leukaemia.Neurotoxic side effects in children with refractory or relapsed T-cell malignancies treated with nelarabine based therapy.Nelarabine toxicity in children and adolescents with relapsed/refractory T-ALL/T-LBL: can we avoid throwing the baby out with the bathwater?The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience.
P2860
Q24602387-8BA13791-3846-4E45-B122-A04B64A3D956Q26746934-CC33CE04-D90A-4372-B9AF-5A56D174632EQ26797513-80FEEE03-ED8B-44D7-8F31-C54C633A6D13Q28080463-14A0132C-6357-4B88-B38E-325D75D0B2B6Q30240892-C8C162FB-374C-4F18-A0B4-467238AEB84AQ30300395-246B36AD-ECE1-4F1A-8341-86FDF3D23437Q33711119-FF15CF46-BA3C-4509-A55B-A73990FABF2AQ35039727-83A7724F-84FC-4642-BC3E-EFA6642FCBD5Q36508149-F9B93A30-8794-491C-A8FC-BB632C4BA53EQ37166753-2FBDCFE6-5901-4273-A44B-35D2D20A1DC4Q37360025-E1BD06DE-7A29-4FCF-BB4A-B8C105F07D4BQ38097334-F92C8359-7301-4A2D-BBC3-810811FA7BB8Q38102065-8ABE9D8E-9FCD-4E43-A71C-D6296B46C8B2Q38102619-EAB8C7D4-08F4-486E-A623-C1971DB51BE9Q38198998-C789324D-EDFD-4EB4-BB67-3D17910C5366Q38644266-2DB21471-6421-418A-988B-E505647D24DEQ38779952-69562EF6-3535-4D2E-853F-CB3D37C4592BQ39368957-1EC0398C-DA48-4326-9562-81C18652FCA2Q40843011-D2CBBE23-95C4-40D0-A0C0-62E5E2BB5BCAQ41847188-F9BEC0E5-B8E0-4B05-AED5-9183EF4A4A7EQ41998600-D12A3579-1127-4CF2-AE34-F73014624979Q46294823-E3CBF4D1-8C74-4326-B1E4-F74014D4C4A3Q47774455-B890293F-8E6E-44AD-8A8C-AABC3C3FD276Q48298283-F5A13311-2B35-4BD0-B5E1-A0174EB81F03Q50168849-5ED94E7D-9CB3-4906-8700-271C8F15F99CQ54699874-1FB224D1-002A-4B91-91E6-333920A29713
P2860
Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Pilot study of nelarabine in c ...... the Children's Oncology Group
@ast
Pilot study of nelarabine in c ...... the Children's Oncology Group
@en
type
label
Pilot study of nelarabine in c ...... the Children's Oncology Group
@ast
Pilot study of nelarabine in c ...... the Children's Oncology Group
@en
prefLabel
Pilot study of nelarabine in c ...... the Children's Oncology Group
@ast
Pilot study of nelarabine in c ...... the Children's Oncology Group
@en
P2093
P2860
P356
P1476
Pilot study of nelarabine in c ...... the Children's Oncology Group
@en
P2093
Bruce M Camitta
Meenakshi Devidas
Michael J Borowitz
Naomi Winick
Stephen B Linda
William L Carroll
P2860
P304
P356
10.1200/JCO.2011.40.8724
P407
P577
2012-06-25T00:00:00Z